E

Enveda

HealthDrug DiscoveryB2B

Enveda is an AI drug discovery startup that has raised $311 million. The company uses artificial intelligence to accelerate the drug discovery process. This funding round doubles its valuation to $2 billion, indicating significant investor confidence in its technology and approach to developing new therapeutics.

Total raised
Undisclosed
tracked to date
Latest round
$311 million
Sep 23, 2026
Press coverage
2
outlets tracked

Is this your company?

Claim this profile to get matched with investors who fund Health startups.

Claim this profile →

Funding history

  1. 1
    $311 millionSep 23, 2026
    Announcement ↗

Enveda in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile